Antigen News and Research

RSS

New microbubble-assisted ultrasound-guided immunotherapy helps improve anti-tumor immunity

Researchers at UT Southwestern have developed a first-of-its-kind ultrasound-guided cancer immunotherapy platform that delivers immune-stimulating agents to cells for the development of systemic anti-tumor immunity.

7 Jun 2022

Can dogs accurately detect COVID-19?

Researchers evaluate the accuracy of using dogs to smell and identify the presence of SARS-CoV-2 in infected and non-infected individuals.

6 Jun 2022

Details of SARS-CoV-2 seroprevalence surveys supported by the US CDC

Researchers reviewed and analyzed data from SARS-CoV-2 serosurveys supported by the United States Centers for Disease Prevention and Control in the low- and middle-income countries.

6 Jun 2022

COVID-19's economic impact on healthcare systems, societies, and the population

In a recent study review posted to the medRxiv* preprint server, researchers evaluated the economic and medical costs incurred due to the coronavirus disease 2019 (COVID-19) pandemic.

6 Jun 2022

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

A recent phase 1/2 study under review at the Nature Portfolio journal and posted to the Research Square* preprint server demonstrated that a peptide-centered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) T-cell activator, CoVac-1, was efficient in B-cell deficient people.

6 Jun 2022

Immune responses may exist on a finer spectrum than previously believed

Researchers from McGill University and the US National Cancer Institute (NCI) have made some surprising discoveries about our immune system.

3 Jun 2022

Genetically engineered immune cells target cancer cells that may be responsible for leukemia relapse

Genetically engineered immune cells successfully target the specific cancer cells that may be responsible for relapse of acute myeloid leukemia (AML), a type of blood cancer, and proved effective in animal models of the disease, according to a preclinical study by investigators at Weill Cornell Medicine.

2 Jun 2022

MD Anderson and National Resilience launch the Cell Therapy Manufacturing Center

The University of Texas MD Anderson Cancer Center and National Resilience, Inc., today announced the launch of a joint venture, the Cell Therapy Manufacturing Center, to accelerate the development and manufacturing of innovative cell therapies for patients with cancer.

2 Jun 2022

The effects of accessory protein mutations and other non-spike mutations on SARS-CoV-2 pathogenesis

Researchers looked into the role played by the accessory proteins using synthetic genomics assembly technology

2 Jun 2022

Inviting asymptomatic people to be screened for prostate cancer should be approached with caution

Inviting people who don't have symptoms to be screened for prostate cancer is not currently recommended and should be approached with caution because, for most men, the benefit is small and uncertain and there are clear harms, warn experts in The BMJ today.

1 Jun 2022

Study shows the SARS-CoV-2 accessory protein ORF7a inhibits HLA-I surface expression levels in human cells

Researchers identified a single viral gene product, the accessory factor ORF7a, facilitating SARS-CoV-2 immune evasion by downregulating the surface expression of MHC class I molecules.

1 Jun 2022

Evidence on COVID-19 vaccine effectiveness and duration of protection against Omicron

Researchers reported the vaccine effectiveness and duration of immunity against SARS-CoV-2 Omicron.

31 May 2022

The effect of CMV serostatus on humoral and cellular measures of vaccine responses after 2 and 3 doses of SARS-CoV-2 mRNA vaccines in older adults

Researchers evaluated the impact of CMV seropositivity on humoral and cellular immune responses generated after double and/or triple mRNA vaccination against SARS-CoV-2 among the elderly.

31 May 2022

Study evaluates protection conferred by prior infection and vaccination against the SARS-CoV-2 Omicron variant within the California state prison system

A recent study evaluated the protection conferred by mRNA vaccines and prior infection against the SARS-CoV-2 Omicron variant.

31 May 2022

Antigen News and Research

New microbubble-assisted ultrasound-guided immunotherapy helps improve anti-tumor immunity

Can dogs accurately detect COVID-19?

Details of SARS-CoV-2 seroprevalence surveys supported by the US CDC

COVID-19's economic impact on healthcare systems, societies, and the population

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

Immune responses may exist on a finer spectrum than previously believed

Genetically engineered immune cells target cancer cells that may be responsible for leukemia relapse

MD Anderson and National Resilience launch the Cell Therapy Manufacturing Center

The effects of accessory protein mutations and other non-spike mutations on SARS-CoV-2 pathogenesis

Inviting asymptomatic people to be screened for prostate cancer should be approached with caution

Study shows the SARS-CoV-2 accessory protein ORF7a inhibits HLA-I surface expression levels in human cells

Evidence on COVID-19 vaccine effectiveness and duration of protection against Omicron

The effect of CMV serostatus on humoral and cellular measures of vaccine responses after 2 and 3 doses of SARS-CoV-2 mRNA vaccines in older adults

Study evaluates protection conferred by prior infection and vaccination against the SARS-CoV-2 Omicron variant within the California state prison system

Evaluating tixagevimab plus cilgavimab against SARS-CoV-2

Prevalence of SARS-CoV-2 infection during Omicron BA.2/BA.2.12.1 surge in New York

Sarbecovirus open reading frame 7a suppresses major histocompatibility complex-I antigen presentation

First-of-its-kind platform generates antitumor immunity and improves responses to checkpoint inhibitors

Direct comparison of immune memory responses to four COVID-19 vaccines

Investigating post-COVID complaints after Delta versus Omicron variant infections

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics